Gene · 2525
FUT3: fucosyltransferase 3 (Lewis blood group)
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. FUT3: fucosyltransferase 3 (Lewis blood group). Genes, record 2525. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2525
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P21217 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3 | 361 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents29
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 46742 | P21217 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 46743 | P21217 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 46744 | P21217 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 46745 | P21217 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 574 | P21217 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 3901 | P21217 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 574 | P21217 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 3901 | P21217 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 32998 | P21217 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 32999 | P21217 | Espacenet |
1 to 10 of 29
See all 29 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants640
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | FUT3 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| U01CA210170 | Using markers to improve pancreatic cancer screening and surveillance: a multi-center study | 4 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30DK056338 | Texas Medical Center Digestive Diseases Center | 3 | 2025 |
| R01AI036040 | STRUCTURAL STUDIES ON ROTAVIRUS | 3 | 2025 |
| R01AI080656 | Regulation of Rotavirus Replication | 3 | 2025 |
| K24AI141744 | Understanding protection against norovirus at the maternal-child interface | 2 | 2025 |
| P20GM125498 | Translational Global Infectious Diseases Research Center | 2 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 2 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 640Source NIH's project files
See all 640 nih grantsPapers1,387
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CLDN18 as a novel junctional biomarker enhancing multi-gene classification of pancreatic cancer. | Transl Oncol | 2026 | 42691511 | PubTator, text mining | PubMed |
| Genetically determined ABO blood group, secretor status, Lewis antigens, and panNEN risk. | Endocr Relat Cancer | 2026 | 42659511 | PubTator, text mining | PubMed |
| Lewis antigen and antibody testing as practical first-line approaches for detecting CA19-9 non-producers. | Transfus Apher Sci | 2026 | 42302476 | PubTator, text mining | PubMed |
| FUCA2 Sustains AKT Signaling and Suppresses Senescence by Antagonizing FUT3-Mediated ErbB3 Fucosylation in Lung Adenocarcinoma. | Adv Sci (Weinh) | 2026 | 42299774 | PubTator, text mining | PubMed |
| Early postoperative carbohydrate antigen 19-9 normalization drives prognosis after pancreatic ductal adenocarcinoma resection. | J Gastrointest Surg | 2026 | 42173352 | PubTator, text mining | PubMed |
| A New CA19-9 Cutoff Value Identifies Lewis Antigen Status and Refines Prognostic Stratification in PDAC. | Clin Cancer Res | 2026 | 42162970 | PubTator, text mining | PubMed |
| Lewis blood group genetic and phenotypic diversity in a Thai population. | Transfus Apher Sci | 2026 | 42119257 | PubTator, text mining | PubMed |
| Decoding the HMO‒microbiome axis: bridging maternal milk to infant health outcomes. | Gut Microbes | 2026 | 41888026 | PubTator, text mining | PubMed |
| Prognostic Value of Combined Carbohydrate Antigen 19-9 and Duke Pancreatic Monoclonal Antigen Type 2 Assessment in Biliary Tract Cancer. | Ann Surg Oncol | 2026 | 41886033 | PubTator, text mining | PubMed |
| A Sequential Proteomic Relay Defines a Decade-long Pre-diagnostic Window for Pancreatic Cancer. | Cancer Diagn Progn | 2026 | 41778239 | PubTator, text mining | PubMed |
1 to 10 of 1,387
See all 1,387 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2525
GET https://conductscience.org/api/genes/v1/2525/patents?page=2